関連する実験動画
Updated: Jul 19, 2026
12:51
Murine Model of Hindlimb Ischemia
Published on: January 21, 2009
p66ShcAは,後肢のイシュケミアに対する組織反応を調節する
Germana Zaccagnini1, Fabio Martelli, Pasquale Fasanaro
1Laboratorio di Patologia Vascolare, Istituto Dermopatico dell'Immacolata-IRCCS, Rome, Italy.
Circulation
|June 3, 2004
まとめ
p66ShcAタンパク質が欠けていたマウスは, ischemia と reperfusion の後に組織損傷と細胞死亡の減少を示した. これは,p66ShcAがこれらの損傷経路において重要な役割を果たし,潜在的な治療目標を提供することを示唆しています.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- 生理学 生理学とは
背景:
- 酸化ストレスは,イシュケミアとイシュケミア/再注射 (I/R) 損傷の中心にある.
- p66ShcA-nullマウスは,反応性酸素種が減少し,酸化ストレスによる細胞死に対する抵抗性が向上した.
研究 の 目的:
- 急性イシュケミアとI/Rの後の組織損傷におけるp66ShcAの役割を調査する.
- p66ShcAの欠乏が,不全性損傷に対する感受性を変化させるかどうかを判断する.
主な方法:
- p66ShcA野生型およびp66ShcA-nullマウスにおける片側後肢性缺血およびI/Rの誘導.
- 血液 perfusion,組織損傷 (毛細血管密度,筋肉繊維死滅),およびアポトーシスレベルの評価.
- シミュレートされた不血症条件下での孤立した細胞のインビトロ分析.
主要な成果:
- p66ShcA-nullのマウスは,野生型と比較して,毛細血管密度減少と筋肉繊維死滅が著しく少ないことを示しました.
- アポプトティック内皮細胞とミオファイバーの低レベルは,p66ShcA-nullマウスのポスト-イシュケミアで観察されました.
- p66ShcA-nullマウスの細胞は,アポトーシスに対する耐性を示し, in vitroでは酸化ストレスが軽減されました.
結論:
- p66ShcAは,急性イシュケミアとI/Rによって活性化された細胞死経路において重要な役割を果たします.
- p66ShcAをターゲットにすることで,不全性組織の損傷を軽減する潜在的な治療戦略が提示されます.
関連する概念動画
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...